Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5118 Target Snapshot

Replicase polyprotein 1ab · SINGLE PROTEIN · Severe acute respiratory syndrome-related coronavirus

313Compounds
65Assays
1Approved Drugs
322.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P0C6X7. Use UniProt P0C6X7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P0C6X7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Replicase polyprotein 1ab as ChEMBL target CHEMBL5118, mapped to UniProt P0C6X7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Replicase polyprotein 1ab
SINGLE PROTEIN · Severe acute respiratory syndrome-related coronavirus
As of 2026-09-14
ChEMBL target ID
CHEMBL5118
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P0C6X7
Replicase polyprotein 1ab
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Replicase polyprotein 1ab is the right protein anchor across sources, using UniProt P0C6X7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelReplicase polyprotein 1ab
UniProt AccessionP0C6X7
Component TypeProtein
Sequence Length7073 aa

Replicase polyprotein 1ab

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Replicase polyprotein 1ab, mapped to UniProt P0C6X7. Sequence length is 7073 aa.

Mapped IDP0C6X7
Review nameReplicase polyprotein 1ab
OrganismSevere acute respiratory syndrome-related coronavirus
Clinical Profile

Clinical Phase Distribution

1
Approved
2
Phase III
2
Phase II
2
Phase 0.5
Assay Mix

Activity Type Distribution

IC50264.0
KI50.0
EC505.0
KD3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5396377 9.85 IC50 0.141 Preclinical
CHEMBL5401656 9.1 IC50 0.8 Preclinical
CHEMBL4777223 8.4 IC50 4.0 Preclinical
CHEMBL4777223 8.31 Ki 4.94 Preclinical
CHEMBL2435614 8.2 Ki 6.3 Preclinical
CHEMBL497141 8.12 Ki 7.5 Preclinical
CHEMBL5411560 7.29 IC50 51.7 Preclinical
CHEMBL213054 7.28 Ki 53.0 Preclinical
CHEMBL5398458 7.23 IC50 59.0 Preclinical
CHEMBL5169323 7.21 IC50 61.0 Preclinical
Distribution

pChEMBL Value Distribution

70
5.0
22
5.5
16
6.0
2
6.5
5
7.0
0
7.5
4
8.0
0
8.5
1
9.0
1
9.5
pChEMBL
Assay Landscape

Assay Landscape

65
Total Assays
229
Tested Compounds
1
Assay Types
Binding — 65 assays, 229 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 44 136 5.0
single protein format 17 72 5.5
cell-based format 4 21 4.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine